BackXenetic Biosciences- Warrants (19/07/2024) Overview
Xenetic Biosciences Inc - Warrants (19/07/2024)

Xenetic Biosciences- Warrants (19/07/2024) P/E Ratio

Xenetic Biosciences- Warrants (19/07/2024) (XBIOW) has a P/E ratio of -3.92, below the Healthcare sector average of 25.75.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-3.92

P/E Ratio

-3.92

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Xenetic Biosciences- Warrants (19/07/2024) (XBIOW) FAQ

As of the most recent data, XBIOW shows a P/E ratio of -3.92. That is below the Healthcare sector average of 25.75. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 25.75. Xenetic Biosciences- Warrants (19/07/2024) is at -3.92, which is lower that average. That is roughly 115.2% below the sector mean. Use the comparison chart on this page to see how XBIOW stacks up against individual peers as well.

Investors watch XBIOW's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Xenetic Biosciences- Warrants (19/07/2024)'s latest reading is -3.92. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Xenetic Biosciences- Warrants (19/07/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -3.92) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 25.75, while XBIOW is at -3.92. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.